국가: 오스트레일리아
언어: 영어
출처: APVMA (Australian Pesticides and Veterinary Medicines Authority)
CEFOVECIN AS SODIUM SALT
ZOETIS AUSTRALIA PTY LTD
cefovecin (as Na)(80mg/mL)
PARENTERAL LIQUID/SOLUTION/SUSPENSION
CEFOVECIN AS SODIUM SALT ANTIBIOTIC Active 80.0 mg/ml
10mL
VM - Veterinary Medicine
ZOETIS AUSTRALIA
CAT | DOG | BITCH | CASTRATE | CAT - QUEEN | CAT - TOM | KITTEN | PUPPY
ANTIBIOTIC & RELATED
BACTERIAL SKIN DISEASE | ESCHERICHIA COLI (E. COLI) | INFECTIONS OF THE URINARY TRACTS | INFECTIONS SENSITIVE TO CEFOVECIN | PORPHYROMONAS SPP | PREVOTELLA SPP | PROTEUS MIRABILIS | STAPHYLOCOCCUS INTERMEDIUS | STREPTOCOCCUS CANIS | DEEP PYODERMAS | ESCHERICHIA COLI | GROUP D STREPTOCOCCUS | INCLUDING B-LACTAMASE PRODUCIN | INCLUDING SECONDARY INVADERS | KLEBSIELLA SPP. | PROTEUS SPP. | PSEUDOMONAS AERUGINOSA | SEBORRHOEIC DERMATITIS | STAPHYLOCOCCUS SPP.
Poison schedule: 4; Withholding period: WHP: N/A; Host/pest details: CAT: [BACTERIAL SKIN DISEASE, ESCHERICHIA COLI (E. COLI), INFECTIONS OF THE URINARY TRACTS, INFECTIONS SENSITIVE TO CEFOVECIN, PORPHYROMONAS SPP, PREVOTELLA SPP, PROTEUS MIRABILIS, STAPHYLOCOCCUS INTERMEDIUS, STREPTOCOCCUS CANIS]; DOG: [BACTERIAL SKIN DISEASE, ESCHERICHIA COLI (E. COLI), INFECTIONS OF THE URINARY TRACTS, INFECTIONS SENSITIVE TO CEFOVECIN, PORPHYROMONAS SPP, PREVOTELLA SPP, PROTEUS MIRABILIS, STAPHYLOCOCCUS INTERMEDIUS, STREPTOCOCCUS CANIS]; Poison schedule: 4; Withholding period: ; Host/pest details: CAT: [BACTERIAL SKIN DISEASE, ESCHERICHIA COLI (E. COLI), INFECTIONS OF THE URINARY TRACTS, INFECTIONS SENSITIVE TO CEFOVECIN, PORPHYROMONAS SPP, PREVOTELLA SPP, PROTEUS MIRABILIS, STAPHYLOCOCCUS INTERMEDIUS, STREPTOCOCCUS CANIS]; DOG: [BACTERIAL SKIN DISEASE, ESCHERICHIA COLI (E. COLI), INFECTIONS OF THE URINARY TRACTS, INFECTIONS SENSITIVE TO CEFOVECIN, PORPHYROMONAS SPP, PREVOTELLA SPP, PROTEUS MIRABILIS, STAPHYLOCOCCUS INTERMEDIUS, STREPTOCOCCUS CANIS]; Antibiotic injection for the treatment of bacterial skin, and urinary tract infections sensitive to cefovecin in dogs and cats and for the treatment of severe infections of gingival and periodontal tissues in dogs.DO NOT USE in food producing species of animals or guinea pigs. FOR USE ONLY in dogs & cats where indicated by antibiotic sensitivity testing according to principles of prudent use. See Restraints and Precautions also.
Registered
2023-07-01
COMPANY NAME: PRODUCT NAME: APVMA APPROVAL NO: ZOETIS AUSTRALIA PTY LTD CONVENIA 60461/106071 LABEL NAME: CONVENIA SIGNAL HEADINGS: PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY READ SAFETY DIRECTIONS CONSTITUENT STATEMENTS: CEFOVECIN 80 mg/mL (as sodium salt) CLAIMS: Antibiotic injection for the treatment of bacterial skin, and urinary tract infections sensitive to cefovecin in dogs and cats and for the treatment of severe infections of gingival and periodontal tissues associated with Porphyromonas spp. and Prevotella spp in dogs. Convenia (cefovecin) is indicated for the treatment of bacterial infections sensitive to cefovecin in dogs and cats with the following conditions: DOGS: Skin infections including bacterial folliculitis, wounds, and abscesses caused by susceptible strains of Staphylococcus intermedius, Streptococcus canis (Group G, haemolytic), Escherichia coli and Proteus mirabilis. Urinary tract infections (cystitis) associated with susceptible strains of Escherichia coli, Proteus mirabilis and Staphylococcus intermedius. As adjunctive treatment to mechanical or surgical periodontal therapy in the treatment of severe infections of gingival and periodontal tissues associated with Porphyromonas spp.and Prevotella spp. CATS Skin infections including abscesses and wounds caused by susceptible strains of Pasteurella multocida, Streptococcus canis (Group G, beta haemolytic), and Staphylococcus intermedius. Urinary tract infections associated with susceptible strains of Escherichia coli. NET CONTENTS: 10mL when reconstituted. Pack Contains: 1 vial Convenia RLP APPROVED 1 x 10 mL Water for Injection DIRECTIONS FOR USE: Reconstituted product: Store refrigerated in original carton and use within 28 days of reconstitution. RESTRAINTS: DO NOT USE in food producing species of animals or guinea pigs. FOR USE ONLY in dogs and cats where indicated by antibiotic sensitivity testing according to principles of prudent use. CONTRAINDICATIONS: Convenia should not be administered to 전체 문서 읽기
PRODUCT NAME: CONVENIA® PAGE: 1 OF 4 This revision issued: October, 2015 SAFETY DATA SHEET Issued by: Zoetis Australia Pty Ltd Phone: 1800 814 883 POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA, (0800 764 766 IN NEW ZEALAND) SECTION 1 - IDENTIFICATION OF THE MATERIAL AND SUPPLIER ZOETIS AUSTRALIA PTY LTD ABN 94 156 476 425 Level 6, 5 Rider Blvd Rhodes NSW 2138 AUSTRALIA Tel: 1800 814 883 Fax: (02) 8876 0444 Email: australia.animalhealth@zoetis.com CHEMICAL NATURE: Cefovecin is a synthetic broad-spectrum antibacterial agent from the cephalosporin class of chemotherapeutic agents. TRADE NAME: CONVENIA® ANTIBIOTIC INJECTION OTHER NAMES: Cefovecin sodium; (6R,7R)-7-[[(2Z)-(2-amino-4- thiazolyl)(methoxyimino)acetyl]amino]-8-oxo-3-[(2S)-tetrahydro-2-furanyl]-5-thia-1- azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid, monosodium salt. PRODUCT USE: Antibiotic injection for the treatment of bacterial infections in dogs and cats. CREATION DATE: MAY, 2008 THIS VERSION ISSUED: OCTOBER, 2015 and is valid until September, 2018. SECTION 2 - HAZARDS IDENTIFICATION STATEMENT OF HAZARDOUS NATURE This product is classified as: Not classified as hazardous according to the criteria of SWA. Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code. RISK PHRASES: Not Hazardous - No criteria found. SAFETY PHRASES: S22, S24/25. Do not breathe dust. Avoid contact with skin and eyes. SUSMP CLASSIFICATION: S4 ADG CLASSIFICATION: None allocated. Not a Dangerous Good under the ADG Code. UN NUMBER: None allocated E E E M M M E E E R R R G G G E E E N N N C C C Y Y Y O O O V V V E E E R R R V V V I I I E E E W W W PHYSICAL DESCRIPTION & COLOUR : Freeze dried cake of Cefovecin sodium in a multi-use vial for reconstitution with 10mL of sterile water for injection. ODOUR: No data. MAJOR HEALTH HAZARDS: no significant risk factors have been found for this product. This product is a cephalosporin antibiotic. Any person with a history of allergies to this or the penicillin class of antibiotics should avoid all contact w 전체 문서 읽기